Research and Development
This group unites PF patients, caregivers, researchers and medical professionals in a platform to... View more
Organizer:
- Organized by
-
-
Study: Health and Economic Burden Rises Before an IPF Diagnosis
-
Study: Health and Economic Burden Rises Before an IPF Diagnosis
Idiopathic pulmonary fibrosis (IPF) increases a person’s health and economic burden years before it is diagnosed, a multi-year Canadian study shows.
The research, “Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada,” appeared in the journal ClinicoEconomics and Outcomes Research.
IPF is a progressive disease that diminishes a person’s quality of life. In addition to the health burden it represents, it can be expensive.
To better inform patients, doctors and policy-makers, a research team decided to evaluate the health and economic burdens of IPF in Quebec Province. They evaluated records collected between 2006 and 2011 in the province, which represents 23 percent of Canada’s population.
Read more about this study here: “Health and Economic Burden Rises Before an IPF Diagnosis, Study Finds“
-
0 Replies
Sorry, there were no replies found.
Log in to reply.